| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 1.5K | 5.7% |
| Total Income | 1.6K | 6.4% |
| Expenditure | 1.3K | 5.9% |
| PBT | 312.74 | 8.5% |
| Net Profit | 215.48 | 15.5% |
| OPM | 24.43% | 0.04pp |
| NPM | 13.79% | 1.09pp |
| EPS | 13.08 | 15.6% |
Gland Pharma Reports Q1 2025 Financial Results with 8.81% Profit Growth
05 Aug 2025 · 5 Aug 2025, 04:27 pm
Summary
Gland Pharma Limited has reported a profit growth of 8.81% in Q1 2025. The company's Board of Directors has approved the un-audited financial results for the quarter ended June 30, 2025. The review report has been prepared in compliance with Indian Accounting Standards (Ind AS) and other accounting principles generally accepted in India.
Key Highlights
- 1
Q1 2025 financial results reported
- 2
8.81% profit growth
- 3
Un-audited financial results approved by the Board of Directors
- 4
Review report prepared in compliance with Ind AS and other accounting principles
Management Comments
N
Not provided
Not provided
Informational and educational content only. Not investment advice.